This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its structure, featuring a pyrrolidine ring and difluorophenyl group, makes it valuable for developing compounds targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. It has been explored in the creation of selective inhibitors or activators of specific receptors in the brain, contributing to treatments for conditions like depression, anxiety, and cognitive impairments. Additionally, its chiral nature allows for the development of enantiomerically pure drugs, enhancing efficacy and reducing side effects. Researchers also investigate its potential in designing novel drugs for metabolic and inflammatory diseases due to its unique chemical properties.